APPENDIX F - FY 2000 OST Research Contracts, Interagency Agreements and Cooperative Research and Development Agreement
October 1, 1999 – September 30, 2000
Air Force Office of Scientific Research (AFOSR) (FDA-224-98-6005). Infrared fiber and wavelength testing for the Air Force.
Armed Forced Institute of Pathology (AFIP) (FDA-224-82-5000). Tissue preparation and analysis of cardiovascular tissue specimens.
Biocon, Incorporated (FDA-223-99-6052). Housing, care and welfare of experimental animals.
Cellular Telecommunications Industry Association (CTIA) (43-00). Health effects of RF emissions from wireless phones.
Department of Defense/Uniformed Services University of the Health Sciences (DOD/USUHS) (FDA-224-98-6015). Maintenance of an animal of the pathophysiology of diabetes for end organ studies.
Department of Energy/Oak Ridge Institute for Science and Education (DOE/ORISE) (FDA-224-88-6064). Establishment and conduct of a research fellowship program.
Environmental Protection Agency (EPA) (FDA-224-00-6062). Understanding and applying mode of action data for single and multiple agents in developmental toxicity risk assessment.
Federal Aviation Administration (FAA) (FDA-224-00-6061). Medical device electromagnetic interference research and testing with medical devices.
National Aeronautics and Space Administration (NASA) (FDA-224-98-6013). Evaluation and testing of a novel fiber optic eye diagnostic instrument in an animal model of diabetes.
National Institute of Environmental Heath Sciences (NIEHS) (FDA-223-94-6015). Support to the Center for Devices and Radiological Health on the effects of ionizing and non-ionizing radiation.
National Institute of Health (NIH) (FDA-224-00-6068). Models of thermal ablation computational, in-vitro, in-vivo.
National Research Council (NRC) (FDA-223-99-6051). National Research Council Associateship Program for the Food and Drug Administration.
Office of Naval Research (ONR) (FDA-224-92-6007). Waveguide and fiber optic delivery for medical applications for free electron lasers.
Program for Appropriate Technology in Health (PATH) (39-99). Effects of storage, materials and stress on glove integrity.
Safeskin Corporation (32-98). Increase in prevalence of latex protein allergy.